| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Ganciclovir | 4.20 | Intermediate level resistance | Recombinant | Details | Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. (Sep 1997) | ||
| Cidofovir | 18.00 | High level resistance | Recombinant | Details | Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. (Sep 1997) | ||
| Foscarnet | 1.20 | No resistance | Recombinant | Details | Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. (Sep 1997) |
| Mutant | Resistances |
|---|---|
| F412L |
Ganciclovir:
|
| F412L |
Cidofovir:
|
| F412L |
Foscarnet:
|
| F412S |
Ganciclovir:
|
| F412S |
Cidofovir:
|
| F412S |
Foscarnet:
|
| F412V |
Ganciclovir:
|
| F412V |
Cidofovir:
|
| F412V |
Foscarnet:
|